Invention Grant
- Patent Title: Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparation method, pharmaceutical composition and application thereof
-
Application No.: US16491459Application Date: 2018-03-07
-
Publication No.: US11066413B2Publication Date: 2021-07-20
- Inventor: Yuguang Wang , Nong Zhang , Tianzhi Wu
- Applicant: GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
- Applicant Address: CN Guangzhou
- Assignee: GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
- Current Assignee: GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
- Current Assignee Address: CN Guangzhou
- Agency: Dilworth IP, LLC
- Priority: CN201710132426.6 20170307
- International Application: PCT/CN2018/078248 WO 20180307
- International Announcement: WO2018/161910 WO 20180913
- Main IPC: C07D491/044
- IPC: C07D491/044 ; C07D473/00 ; C07D487/04 ; A61K31/519

Abstract:
Disclosed in the present invention is an aminopyrimidine five-membered heterocyclic compound, and an intermediate, preparation method, pharmaceutical composition and application thereof. The aminopyrimidine five-membered heterocyclic compound provided by the present invention has a significant antagonistic effect on adenosine A2A receptors, and may be used as an antagonist for adenosine A2A receptors to effectively relieve or treat immune tolerance, diseases of the central nervous system, inflammatory diseases and like related diseases, while the preparation method is simple.
Public/Granted literature
Information query